Eleven children with bronchiolitis induced by respiratory syncytial virus received 10,000 to 70,000 U of recombinant interferon alpha-2a per kg of body weight per day. None developed signs of toxicity, and all but one developed an antiviral state following treatment. Interferon alpha-2a appears to be safe for infants with bronchiolitis. Its efficacy for the treatment of this condition remains to be determined.
No takes yet. Share an insight, caveat, or question.
Portnoy et al. (1988) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: